These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 27010858)
41. miR-211 suppresses epithelial ovarian cancer proliferation and cell-cycle progression by targeting Cyclin D1 and CDK6. Xia B; Yang S; Liu T; Lou G Mol Cancer; 2015 Mar; 14():57. PubMed ID: 25889927 [TBL] [Abstract][Full Text] [Related]
42. Inhibition of Ovarian Epithelial Carcinoma Tumorigenesis and Progression by microRNA 106b Mediated through the RhoC Pathway. Chen S; Chen X; Xiu YL; Sun KX; Zhao Y PLoS One; 2015; 10(5):e0125714. PubMed ID: 25933027 [TBL] [Abstract][Full Text] [Related]
43. MicroRNA‑342‑3p suppresses proliferation and invasion of nasopharyngeal carcinoma cells by directly targeting Cdc42. Shi L; Xiao R; Wang M; Zhang M; Weng N; Zhao X; Zheng XFS; Wang H; Mai S Oncol Rep; 2018 Nov; 40(5):2750-2757. PubMed ID: 30106159 [TBL] [Abstract][Full Text] [Related]
44. NDN is an imprinted tumor suppressor gene that is downregulated in ovarian cancers through genetic and epigenetic mechanisms. Yang H; Das P; Yu Y; Mao W; Wang Y; Baggerly K; Wang Y; Marquez RT; Bedi A; Liu J; Fishman D; Lu Z; Bast RC Oncotarget; 2016 Jan; 7(3):3018-32. PubMed ID: 26689988 [TBL] [Abstract][Full Text] [Related]
45. E2F-1 targets miR-519d to regulate the expression of the ras homolog gene family member C. Sang XB; Zong ZH; Wang LL; Wu DD; Chen S; Liu BL; Zhao Y Oncotarget; 2017 Feb; 8(9):14777-14793. PubMed ID: 28146423 [TBL] [Abstract][Full Text] [Related]
46. Rho GTPase-activating protein deleted in liver cancer suppresses cell proliferation and invasion in hepatocellular carcinoma. Wong CM; Yam JW; Ching YP; Yau TO; Leung TH; Jin DY; Ng IO Cancer Res; 2005 Oct; 65(19):8861-8. PubMed ID: 16204057 [TBL] [Abstract][Full Text] [Related]
47. Effect of StarD13 on colorectal cancer proliferation, motility and invasion. Nasrallah A; Saykali B; Al Dimassi S; Khoury N; Hanna S; El-Sibai M Oncol Rep; 2014 Jan; 31(1):505-15. PubMed ID: 24253896 [TBL] [Abstract][Full Text] [Related]
48. ARHGAP10, a novel human gene coding for a potentially cytoskeletal Rho-GTPase activating protein. Bassères DS; Tizzei EV; Duarte AA; Costa FF; Saad ST Biochem Biophys Res Commun; 2002 Jun; 294(3):579-85. PubMed ID: 12056806 [TBL] [Abstract][Full Text] [Related]
49. Role of the Rho GTPase-activating protein RICS in neurite outgrowth. Nasu-Nishimura Y; Hayashi T; Ohishi T; Okabe T; Ohwada S; Hasegawa Y; Senda T; Toyoshima C; Nakamura T; Akiyama T Genes Cells; 2006 Jun; 11(6):607-14. PubMed ID: 16716191 [TBL] [Abstract][Full Text] [Related]
50. ARHGAP8 is a novel member of the RHOGAP family related to ARHGAP1/CDC42GAP/p50RHOGAP: mutation and expression analyses in colorectal and breast cancers. Johnstone CN; Castellví-Bel S; Chang LM; Bessa X; Nakagawa H; Harada H; Sung RK; Piqué JM; Castells A; Rustgi AK Gene; 2004 Jul; 336(1):59-71. PubMed ID: 15225876 [TBL] [Abstract][Full Text] [Related]
51. [*OPCML gene transferred by recombinant lentiviruses in vitro and its inhibition to ovarian cancer cells]. Yao DS; Li L; Garson K; Vanderhyden BC Zhonghua Fu Chan Ke Za Zhi; 2006 May; 41(5):333-8. PubMed ID: 16762191 [TBL] [Abstract][Full Text] [Related]
52. The R-enantiomer of ketorolac reduces ovarian cancer tumor burden in vivo. Grimes MM; Kenney SR; Dominguez DR; Brayer KJ; Guo Y; Wandinger-Ness A; Hudson LG BMC Cancer; 2021 Jan; 21(1):40. PubMed ID: 33413202 [TBL] [Abstract][Full Text] [Related]
53. Deleted in liver cancer 2 (DLC2) suppresses cell transformation by means of inhibition of RhoA activity. Leung TH; Ching YP; Yam JW; Wong CM; Yau TO; Jin DY; Ng IO Proc Natl Acad Sci U S A; 2005 Oct; 102(42):15207-12. PubMed ID: 16217026 [TBL] [Abstract][Full Text] [Related]
54. StarD13 negatively regulates invadopodia formation and invasion in high-grade serous (HGS) ovarian adenocarcinoma cells by inhibiting Cdc42. Abdellatef S; Fakhoury I; Haddad MA; Jaafar L; Maalouf H; Hanna S; Khalil B; El Masri Z; Hodgson L; El-Sibai M Eur J Cell Biol; 2022 Jan; 101(1):151197. PubMed ID: 34958986 [TBL] [Abstract][Full Text] [Related]
55. TMEM49-related apoptosis and metastasis in ovarian cancer and regulated cell death. Zheng L; Chen L; Zhang X; Zhan J; Chen J Mol Cell Biochem; 2016 May; 416(1-2):1-9. PubMed ID: 27023910 [TBL] [Abstract][Full Text] [Related]
56. StarD13: a potential star target for tumor therapeutics. Jaafar L; Chamseddine Z; El-Sibai M Hum Cell; 2020 Jul; 33(3):437-443. PubMed ID: 32274657 [TBL] [Abstract][Full Text] [Related]
57. Decreased expression of ARHGAP15 promotes the development of colorectal cancer through PTEN/AKT/FOXO1 axis. Pan S; Deng Y; Fu J; Zhang Y; Zhang Z; Ru X; Qin X Cell Death Dis; 2018 Jun; 9(6):673. PubMed ID: 29867200 [TBL] [Abstract][Full Text] [Related]
58. SMAD4 inhibits glycolysis in ovarian cancer through PI3K/AKT/HK2 signaling pathway by activating ARHGAP10. Wu K; Gong W; Sun H; Li W; Chen L; Duan Y; Zhu J; Zhang H; Ke H Cancer Rep (Hoboken); 2024 Jan; 7(2):e1976. PubMed ID: 38230565 [TBL] [Abstract][Full Text] [Related]
59. miR-330 regulates the proliferation of colorectal cancer cells by targeting Cdc42. Li Y; Zhu X; Xu W; Wang D; Yan J Biochem Biophys Res Commun; 2013 Feb; 431(3):560-5. PubMed ID: 23337504 [TBL] [Abstract][Full Text] [Related]
60. Cloning of rat ARHGAP4/C1, a RhoGAP family member expressed in the nervous system that colocalizes with the Golgi complex and microtubules. Foletta VC; Brown FD; Young WS Brain Res Mol Brain Res; 2002 Oct; 107(1):65-79. PubMed ID: 12414125 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]